The acceleration of vaccine development through cloning has broken down the sector's traditionally high barriers to entry, which has attracted the attention of pharmaceutical companies.
Given the rapid acceleration of technological development, any system that relies on a small, elite force of highly trained government agents may be doomed to failure.